Global COVID-19 vaccine roll-out: time to randomise vaccine allocation? thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Acknowledgments: We thank all health care workers, Slovak armed forces, and countless volunteers who helped with the execution of the mass testing campaign. Further, we thank all participants who contributed their time to help curb the pandemic and particularly those who had to quarantine as a result of their or their household’s or contact’s test result.
Funding: This work was supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society 208812/Z/17/Z (to S.Fl.); Wellcome Trust Senior Research Fellowship (to S.Fu., S.A., and K.S.); and Elrha’s Research for Health in Humanitarian Crises (R2HC) Programme funded by the UK Government (DFID), the Wellcome Trust, and the UK National Institute for Health Research (NIHR) (K.V.-Z.). The following funding sources are acknowledged as providing funding for the working group authors: BBSRC LIDP BB/M009513/1 (to D.S.); Bill & Melinda Gates Foundation INV-001754 (to M.Q.); INV-003174 (to K.P., M.J., an
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Vaccinating Africa against COVID-19: riding a roller coaster of poor information
By Heidi Larson & Raji Tajudeen - The Conversation LISTEN
14 HOURS AGO
South Africa's president, Cyril Ramaphosa, receives the COVID-19 vaccine. Leaders have publicly taken the vaccine to encourage others to do the same. - Source: Photo by Brenton Geach/Gallo Images via Getty Images
The story of COVID-19 vaccines and vaccination in Africa is slowly unfolding, as more and more countries across the continent receive shipments of the long-awaited vaccines.
These early shipments won t be enough for all. Some countries have used up the limited supply they have received, while others are still waiting. But some have them, and don t want them. This is a key challenge that vaccination drives face: vaccine reluctance.
Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
Reuters reported that the company is planning to send doses to Europe before the end of the year
Novavax is planning to begin delivering doses of its investigational COVID-19 vaccine to the EU before the end of the year,
Reuters has reported.
An EU official with direct knowledge of the Novavax/EU supply discussions told
Reuters that the deal would be for a total of up to 200 million doses of the vaccine candidate, known as NVX-CoV2373.
Novavax also reportedly told the EU that it is planning to begin deliveries of NVX-CoV2373 to the bloc later this year, with the majority of these doses earmarked for 2022.